Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I study of single and multiple oral doses of ONO-3401 in healthy Japanese adult men
jRCT2071260067Phase 1Recruiting
- Sponsor
- Ono Pharmaceutical
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ONO-3401 (4 arms), sponsored by Ono Pharmaceutical. Primary endpoints: Safety and Tolerability. Started Jul 2026; status: recruiting.
02
Drugs
ONO-3401
Beyond the preview
Go deeper on jRCT2071260067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071260067.